Tolterodine Tartrate
Product Images NDC 0904-6592

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 0904-6592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

F0a989af B18d 4a78 B0ee Dfbb6baf775e 00

This is a description of Tolterodine Tartrate extended-release capsules by the manufacturer Major. The capsules are a unit dose with NDC number 0904-6593-04. The dosage instructions and precautions are not available due to poor quality. The medication should be stored at room temperature, and kept out of reach of children. This information is useful for individuals prescribed Tolterodine Tartrate, or healthcare professionals managing patient medication.*

FDA Label Image

F0a989af B18d 4a78 B0ee Dfbb6baf775e 01

This is a product description for Tolterodine Tartrate extended-release capsules with the NDC code 0904-6592-04. Each capsule contains 2 mg of Tolterodine and it is administered according to the patient's needs. The item is a prescription drug and comes in a unit dose packet with 30 capsules inside. The package includes a patient information sheet. It should be stored at a temperature between 20-25°C, kept away from light and reach of children. The description is made by MAJOR, a drug manufacturing company.*

FDA Label Image

Structure (F0077427 85f6 4e73 9dc1 499d54810ed1 01)

FDA Label Image

Logo (F0077427 85f6 4e73 9dc1 499d54810ed1 02)

FDA Label Image

F0077427 85f6 4e73 9dc1 499d54810ed1 03

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.